|
1
|
Fichel F, Barbe C, Joly P, Bedane C,
Vabres P, Truchetet F, Aubin F, Michel C, Jegou J, Grange F, et al:
Clinical and immunologic factors associated with bullous pemphigoid
relapse during the first year of treatment: A multicenter,
prospective study. JAMA Dermatol. 150:25–33. 2014. View Article : Google Scholar
|
|
2
|
Shah JJ, Stadtmauer EA, Abonour R, Cohen
AD, Bensinger WI, Gasparetto C, Kaufman JL, Lentzsch S, Vogl DT,
Gomes CL, et al: Carfilzomib, pomalidomide, and dexamethasone for
relapsed or refractory myeloma. Blood. 126:2284–2290. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pufall MA: Glucocorticoids and cancer. Adv
Exp Med Biol. 872:315–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Milara J, Lluch J, Almudever P, Freire J,
Xiaozhong Q and Cortijo J: Roflumilast N-oxide reverses
corticosteroid resistance in neutrophils from patients with chronic
obstructive pulmonary disease. J Allergy Clin Immunol. 134:314–322.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmidt S, Rainer J, Ploner C, Presul E,
Riml S and Kofler R: Glucocorticoid-induced apoptosis and
glucocorticoid resistance: Molecular mechanisms and clinical
relevance. Cell Death Differ. 11(Suppl 1): S45–S55. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barnes PJ: Mechanisms and resistance in
glucocorticoid control of inflammation. J Steroid Biochem Mol Biol.
120:76–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vandooren J, Opdenakker G, Loadman PM and
Edwards DR: Proteases in cancer drug delivery. Adv Drug Deliv Rev.
97:144–155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Poplineau M, Doliwa C, Schnekenburger M,
Antonicelli F, Diederich M, Trussardi-Régnier A and Dufer J:
Epigenetically induced changes in nuclear textural patterns and
gelatinase expression in human fibrosarcoma cells. Cell Prolif.
46:127–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Poplineau M, Schnekenburger M, Dufer J,
Kosciarz A, Brassart-Pasco S, Antonicelli F, Diederich M and
Trussardi-Régnier A: The DNA hypomethylating agent,
5-aza-2′-deoxycytidine, enhances tumor cell invasion through a
transcription-dependent modulation of MMP-1 expression in human
fibrosarcoma cells. Mol Carcinog. 54:24–34. 2015. View Article : Google Scholar
|
|
10
|
Nicolaides NC, Galata Z, Kino T, Chrousos
GP and Charmandari E: The human glucocorticoid receptor: Molecular
basis of biologic function. Steroids. 75:1–12. 2010. View Article : Google Scholar :
|
|
11
|
Ishiguro H, Kawahara T, Zheng Y, Kashiwagi
E, Li Y and Miyamoto H: Differential regulation of bladder cancer
growth by various glucocorticoids: Corticosterone and prednisone
inhibit cell invasion without promoting cell proliferation or
reducing cisplatin cytotoxicity. Cancer Chemother Pharmacol.
74:249–255. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
González-Muniesa P, Marrades MP, Martínez
JA and Moreno-Aliaga MJ: Differential proinflammatory and oxidative
stress response and vulnerability to metabolic syndrome in habitual
high-fat young male consumers putatively predisposed by their
genetic background. Int J Mol Sci. 14:17238–17255. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park C-S, Lee YS, Kwon H-S, Lee T, Kim TB,
Moon KA, Yoo B, Moon HB and Cho YS: Chlamydophila pneumoniae
inhibits corticosteroid-induced suppression of metalloproteinase-9
and tissue inhibitor metalloproteinase-1 secretion by human
peripheral blood mononuclear cells. J Med Microbiol. 61:705–711.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jung SH, Wang Y, Kim T, Tarr A, Reader B,
Powell N and Sheridan JF: Molecular mechanisms of repeated social
defeat-induced glucocorticoid resistance: Role of microRNA. Brain
Behav Immun. 44:195–206. 2015. View Article : Google Scholar
|
|
15
|
Bachmann PS, Piazza RG, Janes ME, Wong NC,
Davies C, Mogavero A, Bhadri VA, Szymanska B, Geninson G,
Magistroni V, et al: Epigenetic silencing of BIM in glucocorticoid
poor-responsive pediatric acute lymphoblastic leukemia, and its
reversal by histone deacetylase inhibition. Blood. 116:3013–3022.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang W, Li JJ, Foster PS, Hansbro PM and
Yang M: Potential therapeutic targets for steroid-resistant asthma.
Curr Drug Targets. 11:957–970. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barnes PJ: Corticosteroid resistance in
patients with asthma and chronic obstructive pulmonary disease. J
Allergy Clin Immunol. 131:636–645. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kobayashi Y, Wada H, Rossios C, Takagi D,
Charron C, Barnes PJ and Ito K: A novel macrolide/fluoroketolide,
solithromycin (CEM-101), reverses corticosteroid insensitivity via
phosphoinositide 3-kinase pathway inhibition. Br J Pharmacol.
169:1024–1034. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ito K, Yamamura S, Essilfie-Quaye S, Cosio
B, Ito M, Barnes PJ and Adcock IM: Histone deacetylase 2-mediated
deacetylation of the glucocorticoid receptor enables NF-kappaB
suppression. J Exp Med. 203:7–13. 2006. View Article : Google Scholar
|
|
20
|
Barnes PJ, Adcock IM and Ito K: Histone
acetylation and deacetylation: Importance in inflammatory lung
diseases. Eur Respir J. 25:552–563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Poplineau M, Dufer J, Antonicelli F and
Trussardi-Regnier A: Epigenetic regulation of proMMP-1 expression
in the HT1080 human fibrosarcoma cell line. Int J Oncol.
38:1713–1718. 2011.PubMed/NCBI
|
|
22
|
Frank A, David V, Aurelie T-R, Florent G,
William H and Philippe B: Regulation of MMPs during melanoma
progression: From genetic to epigenetic. Anticancer Agents Med
Chem. 12:773–782. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsapis M, Lieb M, Manzo F,
Shankaranarayanan P, Herbrecht R, Lutz P and Gronemeyer H: HDAC
inhibitors induce apoptosis in glucocorticoid-resistant acute
lymphatic leukemia cells despite a switch from the extrinsic to the
intrinsic death pathway. Int J Biochem Cell Biol. 39:1500–1509.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barillé S, Akhoundi C, Collette M,
Mellerin MP, Rapp MJ, Harousseau JL, Bataille R and Amiot M:
Metalloproteinases in multiple myeloma: Production of matrix
metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction
of MMP-1 by myeloma cells. Blood. 90:1649–1655. 1997.PubMed/NCBI
|
|
25
|
Kelly T, Børset M, Abe E, Gaddy-Kurten D
and Sanderson RD: Matrix metalloproteinases in multiple myeloma.
Leuk Lymphoma. 37:273–281. 2000.PubMed/NCBI
|
|
26
|
Urbaniak-Kujda D, Kapelko-Slowik K, Prajs
I, Dybko J, Wolowiec D, Biernat M, Slowik M and Kuliczkowski K:
Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9),
tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2),
and EMMPRIN (CD147) in multiple myeloma. Hematology. 21:26–33.
2016. View Article : Google Scholar
|
|
27
|
Redic KA, Hough SM and Price EM: Clinical
developments in the treatment of relapsed or relapsed and
refractory multiple myeloma: Impact of panobinostat, the
first-in-class histone deacetylase inhibitor. Onco Targets Ther.
9:2783–2793. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tandon N, Ramakrishnan V and Kumar SK:
Clinical use and applications of histone deacetylase inhibitors in
multiple myeloma. Clin Pharmacol. 8:35–44. 2016.PubMed/NCBI
|
|
29
|
Cai B, Lyu H, Huang J, Wang S, Lee C-K,
Gao C and Liu B: Combination of bendamustine and entinostat
synergistically inhibits proliferation of multiple myeloma cells
via induction of apoptosis and DNA damage response. Cancer Lett.
335:343–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang A, Ma J, Wu M, Qin W, Zhao B, Shi Y,
Jin Y and Xie Y: Aberrant microRNA-182 expression is associated
with glucocorticoid resistance in lymphoblastic malignancies. Leuk
Lymphoma. 53:2465–2473. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kotani A, Ha D, Hsieh J, Rao PK, Schotte
D, den Boer ML, Armstrong SA and Lodish HF: miR-128b is a potent
glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia
cells and exerts cooperative effects with miR-221. Blood.
114:4169–4178. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li G, Bu J, Zhu Y, Xiao X, Liang Z and
Zhang R: Curcumin improves bone microarchitecture in
glucocorticoid-induced secondary osteoporosis mice through the
activation of microRNA-365 via regulating MMP-9. Int J Clin Exp
Pathol. 8:15684–15695. 2015.
|
|
33
|
Genty V, Dine G and Dufer J: Phenotypical
alterations induced by glucocorticoids resistance in RPMI-8226
human myeloma cells. Leuk Res. 28:307–313. 2004. View Article : Google Scholar
|
|
34
|
Genty V, El-Khoury V, Liautaud-Roger F,
Dine G and Dufer J: Nuclear chromatin patterns in 3
glucocorticoid-resistant RPMI-8226 human myeloma cell sub-lines:
Correlations with cell growth and immunological phenotype. Cancer
Biol Ther. 4:832–839. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chomczynski P and Sacchi N: Single-step
method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal Biochem.
162:156–159. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Debret R, Le Naour RR, Sallenave J-M,
Deshorgue A, Hornebeck WG, Guenounou M, Bernard P and Antonicelli
FD: Elastin fragments induce IL-1beta upregulation via NF-kappaB
pathway in melanoma cells. J Invest Dermatol. 126:1860–1868. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Randall MJ, Haenen GRMM, Bouwman FG, van
der Vliet A and Bast A: The tobacco smoke component acrolein
induces glucocorticoid resistant gene expression via inhibition of
histone deacetylase. Toxicol Lett. 240:43–49. 2016. View Article : Google Scholar :
|
|
39
|
Adcock IM, Ito K and Barnes PJ:
Glucocorticoids: Effects on gene transcription. Proc Am Thorac Soc.
1:247–254. 2004. View Article : Google Scholar
|
|
40
|
Ma P, Pan H, Montgomery RL, Olson EN and
Schultz RM: Compensatory functions of histone deacetylase 1 (HDAC1)
and HDAC2 regulate transcription and apoptosis during mouse oocyte
development. Proc Natl Acad Sci USA. 109:E481–E489. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Karius T, Schnekenburger M, Dicato M and
Diederich M: MicroRNAs in cancer management and their modulation by
dietary agents. Biochem Pharmacol. 83:1591–1601. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Trécul A, Morceau F, Gaigneaux A,
Schnekenburger M, Dicato M and Diederich M: Valproic acid regulates
erythro-megakaryocytic differentiation through the modulation of
transcription factors and microRNA regulatory micro-networks.
Biochem Pharmacol. 92:299–311. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Palmieri D, Capponi S, Geroldi A, Mura M,
Mandich P and Palombo D: TNFα induces the expression of genes
associated with endothelial dysfunction through p38MAPK-mediated
downregulation of miR-149. Biochem Biophys Res Commun. 443:246–251.
2014. View Article : Google Scholar
|
|
45
|
Liu P and Wilson MJ: miR-520c and miR-373
upregulate MMP-9 expression by targeting mTOR and SIRT1, and
activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in
human fibrosarcoma cells. J Cell Physiol. 227:867–876. 2012.
View Article : Google Scholar
|
|
46
|
Zhou Y, Li Y, Ye J, Jiang R, Yan H, Yang
X, Liu Q and Zhang J: MicroRNA-491 is involved in metastasis of
hepatocellular carcinoma by inhibitions of matrix metalloproteinase
and epithelial to mesenchymal transition. Liver Int. 33:1271–1280.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ucar A, Vafaizadeh V, Jarry H, Fiedler J,
Klemmt PA, Thum T, Groner B and Chowdhury K: miR-212 and miR-132
are required for epithelial stromal interactions necessary for
mouse mammary gland development. Nat Genet. 42:1101–1108. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huang Q, Gumireddy K, Schrier M, le Sage
C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang K, Handorean AM and Iczkowski KA:
MicroRNAs 373 and 520c are downregulated in prostate cancer,
suppress CD44 translation and enhance invasion of prostate cancer
cells in vitro. Int J Clin Exp Pathol. 2:361–369. 2009.PubMed/NCBI
|
